NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

This is a pay me now or pay me later situation, if the longs are right. Now, before UK approval you can pay in the $.50 cent range, after UK approval it's possible the decimal point could move a place to the right if the media coverage of this new paradigm in cancer treatment receives the right sort of publicity. If the shorts are right, hard to say if the company survives to do more trials.

Note the early phase trials at UCLA, recognize that with Poly-ICLC and/or Keytruda they're achieving 50% survival at 5 years or beyond, but only when they're combined with DCVax-L. If additional trials were ever needed this would totally blow away anything happening in GBM, the regulators can read all about it from the Phase 1, IMHO it would be malpractice not to treat a patient with this off label, but if the regulators want to be deaf, dumb and blind they can ignore it and demand additional trials before an approval.

Gary